tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

iRhythm price target raised to $205 from $183 at Citi

Citi analyst Joanne Wuensch raised the firm’s price target on iRhythm (IRTC) to $205 from $183 and keeps a Buy rating on the shares. The firm is cautious on medical technology entering the Q3 earnings season. Citi believes the outcome of the Section 232 investigation into medical equipment and devices will take time.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1